|
|||||
|
|
The Progressive Supranuclear Palsy Clinical Deficits Scale |
|
| Authors: | Ines Piot MD Kerstin Schweyer MD Gesine Respondek MD Maria Stamelou MD PhD DescribePSP study group ProPSP study group MDS-endorsed PSP study group Philipp Sckopke Thomas Schenk Christopher G. Goetz MD Glenn T. Stebbins PhD Günter U. Höglinger MD |
| Affiliation: | 1. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Department of Neurology, Technical University of Munich, Munich, Germany Department of Neurology, University of Basel, Basel, Switzerland;2. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Department of Neurology, Technical University of Munich, Munich, Germany;3. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Department of Neurology, Technical University of Munich, Munich, Germany Department of Neurology, Hannover Medical School, Hannover, Germany;4. Parkinson's disease and Movement Disorders Department, HYGEIA Hospital and First Department of Neurology, Aiginiteion Hospital, National and Kapodistrian University of Athens, Athens, Greece;5. Department of Psychology, Ludwig-Maximilians-University, Munich, Germany;6. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA;7. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany |
| Abstract: | |
| Keywords: | progressive supranuclear palsy clinical rating scales outcome measures power calculation |